Limited expression of cancer-testis antigens in renal cell carcinoma patients

بواسطة SOGA, NORIHITO, HORI, YASUHIDE, YAMAKADO, KOICHIRO, IKEDA, HIROAKI, IMAI, NAOKO, KAGEYAMA, SHINICHI, NAKASE, KAZUNORI, YUTA, ATSUSHI, HAYASHI, NORIO, SHIKU, HIROSHI, SUGIMURA, YOSHIKI
منشور في 2013

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

بواسطة Ishihara, Mikiya, Tono, Yasutaka, Miyahara, Yoshihiro, Muraoka, Daisuke, Harada, Naozumi, Kageyama, Shinichi, Sasaki, Takeshi, Hori, Yasuhide, Soga, Norihito, Uchida, Katsunori, Shiraishi, Taizo, Sato, Eiichi, Kanda, Hideki, Mizuno, Toshiro, Webster, Gill A., Ikeda, Hiroaki, Katayama, Naoyuki, Sugimura, Yoshiki, Shiku, Hiroshi
الحاوية / القاعدة Cancer Immunol Immunother (2020)